XML 86 R74.htm IDEA: XBRL DOCUMENT v3.25.1
Discontinued Operations - Significant Non-cash Items and Proceeds from Sales of Assets Related to Discontinued Operations (Details) - Cell Therapy Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization $ 0 $ 1,631
Share-based compensation 0 713
Impairment charges 0 641
Loss on disposal of assets $ 0 102
Gain on disposal of business   (8,446)
Cash flows provided by investing activities    
Proceeds from disposal of business   8,000
Proceeds from sale of equipment   $ 37